Benzodiazepine Withdrawal clinical trials

Explore recruiting benzodiazepine withdrawal clinical trials.

Recruiting benzodiazepine withdrawal studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Benzodiazepine Withdrawal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

BACLOFEN FOR IMPROVING BENZODIAZEPINE TITRATION IN BENZODIAZEPINE DEPENDENCE. BABET

France

Phase II and Phase III (Integrated) EU CTIS Study details

Benzodiazepine Withdrawal trials by city

Benzodiazepine Withdrawal in Toronto Benzodiazepine Withdrawal in Vancouver Benzodiazepine Withdrawal in Montreal Benzodiazepine Withdrawal in Calgary Benzodiazepine Withdrawal in Edmonton Benzodiazepine Withdrawal in Ottawa Benzodiazepine Withdrawal in Winnipeg Benzodiazepine Withdrawal in Quebec City Benzodiazepine Withdrawal in Hamilton Benzodiazepine Withdrawal in Kitchener Benzodiazepine Withdrawal in London Benzodiazepine Withdrawal in Halifax Benzodiazepine Withdrawal in New York Benzodiazepine Withdrawal in Los Angeles Benzodiazepine Withdrawal in Chicago Benzodiazepine Withdrawal in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease